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ABSTRACT
Use of Molecular Methods to Authenticate Animal Species and Tissue in Bovine Liver
Dietary Supplements
by Olive Dahm
Dietary supplements containing bovine (subfamily Bovinae) liver are susceptible to fraud
due to the lack of modern detection methods available for processed animal tissues and premium
pricing for dietary supplements. Therefore, the objective of this research was to use molecular
methods to authenticate dietary supplements claiming to contain “bovine liver” or “beef liver”
through the verification of species and animal tissue. A total of 53 bovine/beef liver dietary
supplements were purchased from online sources. The presence of liver was verified with reverse
transcription and real-time PCR testing for microRNA-122 (miR-122), which is highly expressed
in liver tissue. Multiplex real-time PCR targeting domestic cattle (Bos taurus), horse (Equus
caballus), sheep (Ovis aries), and pork (Sus scrofa) was used to verify species. Samples that
failed species identification with multiplex real-time PCR underwent DNA mini-barcoding.
Overall, bovine species were detected in 48/53 liver supplements: 35 samples were confirmed as
B. taurus with multiplex real-time PCR and an additional 13 samples were confirmed as B.
taurus or Bos spp. with DNA mini-barcoding. One sample was positive for domestic cattle and
sheep/lamb, both of which were declared on the label. One product was mislabeled due to the
detection of undeclared pork in addition to beef. MiR-122 was detected in 51 out of 53
supplements, suggesting the presence of liver. Tissue-specific microRNAs can be reliable in
identifying tissue and may be useful in detecting mislabeling in supplements. However, this was
the first study to utilize microRNA for authentication of liver in dietary supplements and more
research is needed to evaluate the specificity of these markers.
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1. Introduction
Dietary supplements are intended to supplement the diet with ingredients such as
vitamins, minerals, amino acids, and herbs or botanicals (FDA, 2018b). However, factors such as
a lack of proper Good Manufacturing Practices (GMPs), ingredient substitution or removal, and
unscrupulous ingredient sourcing can lead to supplement adulteration (Brown, 2017). Under the
Food Drug and Cosmetic (FD&C) Act, dietary supplements are a category of food with labeling
regulations and registry reporting system separate from food and drugs (FDA, 2018b).
Intentional adulteration in dietary supplements typically involves the use of ingredients that are
not listed on the label, such as undeclared drugs, to enhance claimed biologic or metabolic
effectiveness; substitution of declared ingredients with cheaper alternatives; and use of
unapproved non-dietary ingredients (NDIs) (Brown, 2017). Previous market surveys on the
contents of dietary supplements have reported mislabeling rates of 25% for shark cartilage pills
(Hellberg, Isaacs, & Hernandez, 2019), 42% for probiotic supplements (Morovic et al., 2016),
and 58% for botanicals (Newmaster et al., 2013). For example, studies have reported species
substitution, such as alfalfa (Medicago sativa) substituted for elderberry (Sambucus nigra) and
winter skate (Leucoraja ocellata) substituted for shark species (Hellberg et al., 2019; Newmaster
et al., 2013), as well as probiotics that don’t meet label claim or detection thresholds for strains
listed on the label (Morovic et al., 2016 ).
Animal organs are sometimes used in dietary supplements because they contain vitamins,
minerals, and amino acids essential to the human diet (Fayemi et al., 2018). Liver is the most
common animal tissue used in dietary supplements, listed in over 140 known products according
to the Dietary Supplement Label Database (DSLD) (NIH, 2019). Important nutrients found in the
liver include vitamins A, E, B1, B2, B6, and B12; folate; biotin; niacin; and omega-3 fatty acids
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(Fayemi, Muchenge, et al., 2018). Beef is the main declared source of liver and other animal
tissues in dietary supplements, followed by pork, sheep, and chicken (NIH, 2019). Liver as a
dietary ingredient is susceptible to fraud because processing makes it visually appear similar to
other dietary ingredients and there is no established method for tissue identification in processed
dietary ingredient samples or finished dietary supplement products. Previous studies on meat
mislabeling have reported species substitution and species mixtures in food products. For
example, one study on ground meat products reported a mislabeling rate of 20% (Kane &
Hellberg, 2016) and another on organ meat foods reported 31% mislabeling (Köppel et al.,
2013). However, there is currently a lack of research on the mislabeling of dietary supplements
containing liver.
Current molecular laboratory methods for detecting animal or plant ingredients in dietary
supplements include real-time PCR and DNA barcoding. Real-time PCR is a targeted approach
that uses species-specific primers to identify species in real-time (Köppel et al., 2013; Köppel et
al., 2011). The combination of species-specific primers in a multiplex, real-time PCR assay
allows for multiple species to be detected simultaneously. For example, Köppel et al. (2011)
developed a multiplex real-time PCR assay with the commercial name AllHorseTM that
simultaneously detects domestic cattle (Bos taurus) and several common substitute species,
including pig (Sus scrofa), horse (Equus caballus), and sheep (Ovis aries). DNA barcoding uses
universal primers that amplify a short, standardized region of DNA (Herbert, Cywinska, Ball, &
deWaard, 2003). For DNA barcoding of animal tissues, the most common target is a ~655 base
pair (bp) region of the mitochondrial gene coding for cytochrome c oxidase subunit I (COI).
Because DNA degradation occurs during processing, test methods for animal species in
processed products often target shorter regions of DNA called “mini-barcodes” (Hellberg et al.,
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2019; Zahn et al., 2020; Wu et al., 2019). For example, one study reported increased success
when using mini-barcoding compared to full-length DNA barcoding for the detection of species
in shark cartilage dietary supplements (Hellberg et al., 2019). A novel DNA mini-barcode assay
was developed specifically for the identification of animal species in processed foods; however,
it has not yet been tested with dietary supplements (Wu et al., 2019).
Traditionally, histological and immunological methods are used to identify animal tissues
(Sauer et al., 2017). However, identification is difficult with histological methods if the sample is
processed and does not contain intact cells due to processing (Abdullah, 2008). Immunological
methods can become costly and require specific assays (Sauer et al., 2017). RNA-based tests
tend to be unreliable in aged or processed samples because RNA degrades faster than DNA
(Sauer et al., 2017). However, many tissue-specific microRNAs (miRNAs) are relatively stable
(Sauer et al., 2017). MiRNAs are 18-24 nucleotides in length and regulate gene expression by
binding with a fully or partially complementary RNA-Induced Silencing Complex (RISC) that
regulates messenger RNA (mRNA) expression. MiRNAs are more stable post-mortem compared
to mRNA and RNA under normal conditions and in the presence of elevated temperature and
RNases (Na & Park, 2018). Forensics studies use miRNA detection for human fluid and tissue
identification from residual samples (Sauer et al., 2017; Sauer et al., 2016). Although most
miRNAs are conserved across species and in all tissues, miRNA markers have been identified in
various animal tissues and species, resulting in species-specific miRNAs as well as tissuespecific miRNAs (Jin et al., 2009). Due to miRNA tissue specificity, there is potential to use
miRNA to identify animal tissues in dietary supplements.
The objective of this study was to determine whether dietary supplements marketed as
containing “bovine liver” or “beef liver” are accurately labeled with regards to the animal species
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and tissue type. The term “bovine” refers to an animal within the cattle group (subfamily
Bovinae), while “beef “is meat from full-grown bovine/cattle (USDA, 2020b; Merriam-Webster,
n.d.). A combination of DNA barcoding and real-time PCR identified species and miRNA testing
verified the presence of liver.
2. Review of Literature
2.1: Dietary Supplement Regulations
Dietary supplements are regulated separately from food and drugs but are subject to 21
CFR 111 for current GMPs. The U.S. government first defined the standard of identity for
dietary supplements in the Dietary Supplement Health and Education Act of 1994 as an
amendment of the FD&C Act. Dietary supplements contain ingredients, such as vitamins,
minerals, botanicals, and amino acids, intended to supplement the human diet, or a “concentrate,
metabolite, extract, constituent or combination” of any of the criteria listed above (FD&C, 1938).
Dietary supplements are required to be compliant with 21 CFR §101.36 and must include
a “Supplement Facts” panel (FDA, 2018b). Declared label ingredients must be listed on the
Supplement Facts panel or ingredient list and must be present in the dietary supplement. Dietary
supplement product labels and websites can contain nutrient content claims, structure/function
claims and approved health claims. Nutrient claims indicate the levels of nutrients with
established daily values in the product. For example, nutrient content claims can simply be
claiming “100% daily value” of a nutrient on the label. Structure/function claims state the role
that vitamins/minerals have in preventing nutrient deficiency-related diseases or promoting
regular health functions (FDA, 2018b). Structure/function claims may also state how an
ingredient helps promote a healthy lifestyle, such as supporting a healthy weight or sleep.
Despite being able to make these claims for dietary supplements, the label must include a
4

required word-for-word disclaimer that the FDA has not evaluated the statement. FDA approved
health claims may be used on dietary supplement product labels and websites; however,
scientific evidence must support any new health claims, the FDA has to approve the claims, and
the FDA may use enforcement discretion (FDA, 2018a). Drug labels can contain disease-related
terminology such as: treats cardiovascular disease or reduces symptoms of hyperthyroidism.
However, dietary supplements are narrowly limited on health claim usage because they are not
intended to prevent, cure, or mitigate diseases or their symptoms (FD&C, 1938; FDA, 2018b).
This research is important for current GMP (cGMP) compliance for dietary supplements.
Manufacturers must establish product ingredient specifications for identity, purity, strength, and
composition (21 C.F.R. § 111.70, 2020). In addition, manufacturers must have contamination
limits to prevent adulteration and preserve quality (21 C.F.R. § 111.70, 2020). These standards
can be verified using molecular methods.
2.2: Animal Tissues in Dietary Supplements
Dietary supplements sometimes include organ meats because they contain vitamins,
minerals, and amino acids essential to the human diet (Fayemi, Muchenge, Yetim, & Ahhmed,
2018). According to the Dietary Supplement Label Database, the top 10 animal tissues used in
dietary supplements are, in descending order: liver, thymus, spleen, cartilage, pancreas, pituitary,
orchic, kidney, antler velvet, and parotid (NIH, 2019). The most common source of animal
tissues used in dietary supplements is beef (NIH, 2019). Important nutrients found in the liver
include vitamins A, E, B1, B2, B6, and B12; folate; biotin; niacin; and omega-3 fatty acids
(Fayemi, Muchenge, et al., 2018). Liver may also be perceived as “detoxifying” due to early
studies claiming that supplementing the diet with liver can counteract the effects of toxic drug
doses or increase swimming endurance (Ershoff, 1951; 1952). Another group of researchers
5

suggested that nutrient-rich organ meats, such as liver, heart, kidney and brain, would be a good
source of nutrients for malnourished populations (Fayemi et al., 2018). Despite the widespread
availability and popularity of these supplements, no studies have been published evaluating
whether dietary supplements actually contain the tissue declared on the label.
Although animal organs contain essential nutrients for human health, they can also
contain undesirable elements. For example, Hashemi (2018) showed that lead and mercury
concentrations in bovine liver were over the minimal risk level for 15.3% and 8.3% of samples,
respectively, and heavy metal concentrations in meat and organs seemed to fluctuate greatly
between countries of origin. The FDA issued an import alert in 2018 concerning any dietary
supplements contaminated with heavy metals (FDA, 2018c). Although there have been no recalls
or import alerts by the FDA for animal livers, in 2014, they issued a warning letter to a company
selling bovine meat with drug concentrations greater than the allowed amount (FDA, 2014).
Gochfeld and Burger (1987) studied the heavy metals present in the organs of three avian
species. They discovered that zinc and copper were the most abundant in all three duck species
and both sexes of duck tested. Cadmium, cobalt, and mercury were consistently present in trace
amounts. They also found that there was variation in the levels of metals for species and sex for
black ducks (Anas platyrhynthos) and scaup (Aythya marila). Although zinc and copper are
considered essential minerals, they can be toxic depending on the dose. These results emphasize
the importance of the careful selection of species and their organs for human consumption.
The presence of prions in animal tissues can cause disease in humans (Belay, 1999; Belay
& Schonberger, 2005). The prevalence of prion disease in sheep and cattle has not decreased in
the UK, US, and Canada, and recommended efforts should be followed to avoid consumption of
contaminated specimens (Boelaert et al., 2016). Prion contaminated meat is typically removed
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from the food supply, but it is also recommended that consumers avoid eating high-risk animal
parts, such as the spleen and brain. However, there are multiple dietary supplements available on
the U.S. market that contain spleen and brain tissue (Huyben et al., 2018; NIH, 2019). There is
also the risk of spinal cord and central nervous system cross-contamination during processing
(Gangidi & Proctor, 2009). Currently, there is no research on whether dietary supplements
containing animal tissues, such as the brain or spleen, also contain prions.
2.3: Dietary Supplement Adulteration and Misbranding
The FD&C Act of 1938 defines misbranding as a mislabeled, counterfeit, or imitation
product (FD&C, 1938). Fraud, on the other hand, is defined as “the act of defrauding buyers of
food or ingredients for economic gain” (Johnson, 2014). The FDA uses the term Economically
Motivated Adulteration (EMA) to describe the adulteration of a product for economic benefit
(Johnson, 2014).
There are many types of EMA, including dilution with water or a filler, ingredient
replacement with a substitute, and addition of ingredients to mask inferior quality or increase
potencies, such as adding caffeine to dietary supplements containing inherent caffeine such as
kola nut (Cola acuminata) or tea (Camellia sinensis) (FDA, 2017; Newmaster et al., 2013).
Mislabeling includes false declarations of origin, undeclared ingredients, and noncompliance to
label regulations. For example, some dietary supplements contain illegal, unlisted drugs to
enhance dietary supplement effectiveness for structure/function claims (Benatrehina et al., 2018).
Sometimes, cheaper botanical substitutions or fillers replace expensive herbal ingredients
without a label change, such as replacement of Echinacea purpurea with Parthenium
hysterophorus, Ginkgo biloba with Juglans nigra or Oryza sativa, and Rubus idaeus with
Medicago sativa (Newmaster et al., 2013). One study found that 21% of 44 botanical dietary
7

supplements tested contained fillers such as rice (Oryza sativa) and soybean (Glycine max)
(Newmaster et al., 2013). However, it is important to note that dietary supplements and other
food products are allowed to contain incidental additives which are exempt from label
declarations (21 C.F.R. § 101.100, 2020). Incidental additives are defined in 21 C.F.R. § 101.100
(2020) as substances present at insignificant levels that don’t have a functional or technical effect
in the food, processing aids or non-food additive substances that enter the food from contact with
equipment or packaging.
Dietary supplements must meet label claims at the end of shelf life despite any ingredient
sensitivity to degradation (FDA, 2018b). Morovic et al. (2016) found that 42% of 52 probiotic
dietary supplements tested contained undeclared microorganisms or did not contain all of the
probiotics listed on the label. Although probiotics and other ingredients lose viability and
degrade over time, dietary supplement ingredients are required to meet 100% or more of label
claimed quantities throughout the entirety of shelf life, otherwise the product is considered
misbranded by the FDA (21 C.F.R. §101.36, 2020). Although some studies have quantified
dietary ingredients, this thesis research did not quantify the ingredients in bovine liver dietary
supplements.
Some researchers have conducted studies evaluating species fraud in dietary
supplements. A study by Hellberg et al. (2019) identified shark species in shark cartilage dietary
supplements and found species mislabeling, although they did not conduct cartilage presence
verification. Some of the species found in these shark supplements were considered threatened,
vulnerable, or endangered (Hellberg et al., 2019). This study also identified wild rice (Oryza
rufipogon), a common filler. Wallace et al. (2012) used DNA barcoding to identify animal and
plant species in natural health products. These researchers also found similar trends where
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ingredients, such as green tea, were replaced with fillers like rice. Ingredients, such as Korean
ginseng, were also replaced with cheaper or related species not listed on the label, such as
American ginseng. Wallace et al. (2012) also tested shark supplements and found similar
mislabeling results compared to Hellberg et al. (2019).
Although studies have not examined the substitution of animal tissues, there is a strong
economic incentive to substitute one animal species for another. For example, the average retail
price of beef liver sold at five different online sources in the United States in April 2020 was
$6.67/lb, which is more expensive than chicken liver sold online with an average price of
$2.92/lb. This price difference can motivate companies to substitute chicken for beef to make a
profit. Most offal or organ meats are lower in price than muscle meat, however (Fayemi et al.,
2018).
2.3.1: Meat Species Substitution
Dietary supplement manufacturers rely on suppliers for their meat ingredients. Despite
the health consequences of adulteration, market surveys have found that mislabeling is common
among food. Researchers reported that 20.8% of 48 raw ground meat samples purchased from
online specialty stores, butchers, and retail markets were mislabeled in one study (Kane &
Hellberg, 2016). Other researchers found a 15.9% mislabeling rate of 806 raw meat products in
Florida retail markets (Hsieh et al., 1995). Another study found that 31.0% of 29 animal organ
foods- Mousse, Rillettes, and Foie gras- contained undeclared species or different amounts of
species compared to the label claim (Köppel et al., 2013).
Some individuals have allergies or religious affiliations that prevent them from
consuming certain meats. Religious restrictions include halal and kosher. For halal, pork is not
allowed, and beef is allowed with halal processing conditions. For kosher, pork and non-kosher
9

gelatin for capsules is not allowed. Fraud of kosher and halal meats has been reported in the food
supply (Danezis et al., 2016). Allergies can severely endanger the life of an
immunocompromised or allergen-sensitive person when they ingest an inappropriately labeled or
contaminated food. There have been reports of allergic reactions after the ingestion of red meat
and poultry (Hemmer et al., 2016; Wong & Sebaratnam, 2018). Horse meat is taboo, illegal, or
against religious practices for human consumption in the United States and many other countries
(California Attorney General, 2015). However, during the European horsemeat scandal in 2013,
the Food Safety Authority of Ireland (FSAI) found multiple foods containing undeclared
horsemeat (FSAI, 2013).
2.4: Species Identification Methods
Table 1: Summary of benefits and limitations of genetic sample identification techniques.
Method
Applications Benefits
NextSpecies ID
mixed samples
Generation
allowed,
Sequencing
universal primers

DNA
Barcoding

Species ID

Targeted
PCR

Species ID

MiRNA
Detection

Forensics,
Tissue ID,
Disease ID

Database
references,
standard
procedures,
universal primers
mixed samples
allowed,
standard
procedures
Sensitive, stable,
mixed samples
allowed
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Limits
Intact DNA
required, timeconsuming,
expensive, large
amount of data
Only tests
maternal DNA,
pure sample
needed

Source
(Schwarze et
al., 2018)

Primer
interactions,
targeted approach

(Köppel et al.,
2013)

Need tissue- or
species-specific
miRNA and
amplification, no
complete database

(Sauer et al.,
2017)

(Hellberg et
al., 2019;
Weigt et al.,
2012)

Common methods used for species identification include DNA-based techniques, such as
DNA barcoding and PCR. However, none of these methods can detect the presence of specific
tissues in a sample. MiRNAs are a promising biomarker for determining the organs present in a
sample. Table 1 contains a summary of the pros and cons of each detection method is in.
2.4.1: Real-Time PCR
First proposed in 1985, Polymerase Chain Reaction (PCR) is a process of replicating
DNA (Mullis & Faloona, 1987; Saiki et al., 1988). First, denaturation of DNA separates the
double helix into its two strands. The primers anneal to their complementary DNA portions and
DNA polymerase synthesizes new daughter strands attached to the parent strands (Saiki et al.,
1988). This process cycles repeatedly until the achievement of the desired replication amount.
Uses of PCR include the detection of species’ DNA and DNA cloning (Saiki et al., 1988). PCR
is crucial for analyzing samples with degraded or small amounts of DNA.
The processing carried out during the production of dietary supplements can hinder DNA
extraction, which leads to difficulties in obtaining data (Mano et al., 2017). Shear forces,
elevated temperatures, enzymes, and extreme pH conditions damage DNA. Real-time PCR,
where the sample’s DNA is amplified and detected in real-time using fluorescence, is able to
detect the residual DNA. Additionally, real-time PCR can be used for the quantification of DNA
in the sample. Fragmentation can lead to the underestimation of DNA present since the primers
may not be able to bind to their target sequence. Therefore, it is important to have internal
references and controls while conducting real-time PCR to avoid false negatives and false
positives.
Multiplex real-time PCR is advantageous over singleplex real-time PCR because it
detects multiple species in an ingredient mixture (Dalsecco et al., 2018; Kane & Hellberg, 2016;
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Köppel et al., 2013; Köppel et al., 2011; Mohamad et al., 2018). For example, one study
reported the ability of multiplex real-time PCR to verify the presence of chicken and pork in
poultry and meat samples, respectively (Wang et al., 2018). Many multiplex real-time PCR
assays have been developed for the simultaneous detection of multiple species in a sample. For
instance, Köppel et al. (2013; 2011) created a primer cocktail for the detection of cattle, pork,
horse, and sheep (AllHorseTM), as well as a primer cocktail for the detection of pork, chicken,
turkey, and goose (AllPâtéTM). Köppel et al. (2011) found that the AllHorse assay could detect
the species in a mixed sample with total species DNA concentrations as low as 0.32 ng. The only
cross-reactivity (0.1%) they found was horse with donkey (Equus asinus) and mule (mulus). The
AllPâté assay had some cross-reactivity (0.1%) with closely-related avian species and detected
species present at DNA concentrations as low as 0.4 ng for turkey and 0.2 ng for the other targets
(Köppel et al., 2013).
2.4.2: DNA Barcoding
DNA barcoding uses a standardized region of the genome as a species indicator in a pure
sample (Ivanova et al., 2012; Kress & Erickson, 2008). The standard region used for the
identification of animal species with DNA barcoding is a ~650 bp section of the mitochondrial
gene coding for COI (Folmer et al., 1994; Herbert et al., 2003). The circular mitochondrial
genome was first imaged in 1979 and is well conserved in eukaryotes yet different enough to
distinguish between species (Hsu & Coca-Prados, 1979). A universal primer set binds to the
DNA barcode and the resulting sequence is compared to known species’ sequences in a database,
such as GenBank or BOLD. This method has been used for the identification of a range of
animal species in food products, such as meat and poultry samples (Ballin, 2010; Dalsecco et al.,
2018; Hellberg et al., 2017; Kane & Hellberg, 2016; Mano et al., 2017).
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While DNA barcoding is an important method for the identification of animal species in
foods, it does have some limitations. For example, hybrid species cannot be identified through
DNA barcoding because the mitochondrial DNA is inherited maternally. Additionally, samples
containing multiple species often cannot be identified using DNA barcoding, as the simultaneous
amplification of DNA from these species causes a mixed sequencing signal (Hellberg &
Morrissey, 2011; Kane & Hellberg, 2016). In addition, traditional full-length DNA barcoding
using the 650 bp region is not feasible with heavily processed or degraded samples since there is
a risk that the DNA will be fragmented or damaged (Mano et al., 2017). Some researchers have
used mini-barcoding instead, which requires shorter sequences (< 250 bp), to identify species in
processed samples (Hellberg et al., 2017; Hellberg et al., 2019; Wallace et al., 2012). For
example, mini-barcoding with primers developed by Fields et al. (2015) successfully identified
shark species in shark cartilage dietary supplements that failed identification with full-length
barcoding (Hellberg et al., 2019). However, in a study on meat species identification, Hellberg et
al. (2017) found that the universal mini-barcode primers developed by Meusnier et al. (2008)
were not reliable in identifying beef, chicken, and bison in meat and poultry samples. Wu et al.
(2019) tested a different set of mini-barcoding primers on a variety of mammalian, poultry, and
fish species, as well as processed food products, and found that the species could reliably be
determined. Sultana et al. (2018) applied mini-barcoding to processed Malaysian fish products
and found that the barcode marker used was reliable at identifying all 33 fish species tested.
2.5: MiRNA Introduction
MiRNAs are small, non-coding RNAs that can influence tissue differentiation, gene
regulation, disease susceptibility, and growth maturation (Courts & Madea, 2010). The discovery
of miRNAs occurred while researchers studied the lin-4 gene in roundworms (Caenorhabditis
13

elegans), where instead of coding for a protein, this gene encoded a miRNA that targeted the lin14 messenger RNA (mRNA) (Lee et al., 1993).
MiRNAs are typically 18-25 nucleotides long, which makes detection methods difficult
since most methods isolate larger RNA, shown in Figure 1 (Mraz et al., 2009). RNA isolation
methods can lose these small RNAs due to their size or, compared to large RNA molecules, not
contribute significantly to test results. They could also have been considered fragments and
contaminants of larger nucleic acids during quantification, and therefore ignored. Total RNA
extraction does not always extract miRNAs, and additional steps are sometimes needed to isolate
and detect miRNAs (Ma et al., 2018).

Figure 1: Typical RNA extraction that isolates total RNA (Life Technologies Corporation, 2011)
The first step in miRNA formation through the typical canonical processing pathway is
the transcription of primary miRNAs (pri-miRNA) from non-protein coding DNA gene introns
using RNA polymerase II in the nucleus (Courts & Madea, 2010; Gustafson et al., 2016; Wang
et al., 2013). The enzyme Drosha, along with the protein-coding gene DGCR8, separate the primiRNAs into 60-100 nt precursor miRNAs (pre-miRNA). Exportin-5 proteins and the G-protein
Ran export the pre-miRNAs into the cytoplasm where the Dicer enzyme cleaves the pre14

miRNAs into miRNA duplexes, a double-stranded miRNA consisting of a mature strand and a
degrading strand. Each strand is assigned -5p or -3p suffixes, depending on their position
(Gustafson et al., 2016). Upon the formation of the mature miRNA, the strands separate, and the
miRNA guide strand merges with a fully or partially complementary RNA-induced silencing
complex (RISC), which moves to the nucleus to influence mRNA regulation. The degraded
strand typically breaks down but sometimes also has RISC targets (Wang et al., 2013). The
miRNA’s 8-base seed region determines the target RISC and is highly conserved between 15
evaluated animal species, including human, horse, sheep, pork, fish, fruit fly (Drosophila
melanogaster), and cattle (Zorc et al., 2015).
2.5.1: MiRNA Stability
MiRNAs are used in human (Homo sapiens) forensics because they are stable enough to
survive harsh environmental conditions, such as temperature and pH, for prolonged periods and
be detectable at low levels (Courts & Madea, 2010). Sauer et al. (2016) compared miRNA
expression profiles from human bodily fluid samples with varying age and found that miRNAs
were stable and detected even after 35 years (Sauer et al., 2016). Since miRNAs can be tissuespecific, detection can determine whether a victim has fatal wounds with just a residue on a
weapon (Sauer et al., 2017).
Studies in humans have shown that mono-uridylation of pre-miRNAs promotes miRNA
biogenesis and mono-adenylation promotes miRNA stability (Jopling, 2012; Song et al., 2015).
The miRNA’s nucleotide sequence also influences its stability (Bail et al., 2010). Kakimoto et al.
(2016) have shown that a miRNA’s half-life depends on the guanine-cytosine content (GC%),
with GC% above 40 yielding the greatest stability. Bail et al. (2010) found 5 out of 99 miRNAs
had half-lives of 8 h or less. However, 95% of miRNAs studied did not decrease within 8-hours
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and many of these miRNAs are successful with verifying human tissues in aged forensic samples
(Sauer et al., 2017). Therefore, it is important to select stable miRNAs for tissue identification
that will still be present after processing. Bail et al. (2010) also suggested that miRNA stability is
influenced by the cell type, as well as whether the miRNA was intracellular or extracellular.
Fang et al. (2019) found that miRNAs in the blood are stable under ambient conditions. Factors
that affect miRNA degradation in human blood include multiple freeze-thaw cycles and high
concentrations of sodium hypochlorite (Fang et al., 2019). Liver samples may contain trace
amounts of blood that could affect miRNA detection. It is also possible that liver miRNAs are
susceptible to the same degradation conditions as blood miRNAs.
2.6: MiRNA Expression
MiRNAs can be expressed differently in tissues, bodily fluids, and species. Therefore,
they are a good indicator of tissue type and can identify tissues in mixtures where multiple
species and tissues are blended. Tissues exhibit miRNA signatures that can help to identify them
in a sample by detecting a miRNA unique to the tissue or a combination of miRNAs present in
the tissue. For example, researchers found that miR-122 is highly expressed in the liver; miR-483
in connective tissue; miR-1 in heart; and miR-146a, -200a and -b in kidneys (Gustafson et al.,
2016; Jin et al., 2009; Lagos-Quintana et al., 2002). MiRNAs can participate in cell-to-cell
signaling and many are found in bodily fluids (Hollis & Starkey, 2018). They are protected in
these fluids by RNA-binding proteins or extracellular vesicles (Hollis & Starkey, 2018). There
have been four bovine-specific miRNAs discovered by Jin et al. (2009). However, most miRNAs
are conserved across species and it is unknown if these miRNAs are conserved in other species
not yet analyzed. Hanif et al. (2018) found that there were variations in gene copy numbers of
miRNAs between domestic cattle and zebu (Bos indicus) and that miRNAs can have mutation
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differences, most commonly substitution, between species. For example, miRNA tissue
expression in porcine liver includes miR-103 and let-7a (Bae et al., 2018).
Some miRNAs are involved in tissue differentiation and development during growth
phases, such as mir-1 and mir-35 in the development of heart muscle (Hicks et al., 2009; Kwon
et al., 2005; Renalier et al., 2011). MiRNAs that are found abundantly in a tissue may affect the
development of that tissue (Alvarez-Saavedra & Horvitz, 2010; Renalier et al., 2011). For
example, mir-7 is highly expressed in eye tissue in Drosophila and influences eye development
(Li & Carthew, 2005). Since miRNAs are non-coding, they often do not have any phenotypic
effect (Renalier et al., 2011). However, knocking out or modifying an entire miRNA family has
been shown to affect phenotypic development and function (Chen et al., 2014). Interestingly,
some miRNAs have distinct expression patterns when tissue injury is present (Morrison, 2018;
Permenter et al., 2019). MiRNAs are being studied for their use to identify and treat diseases.
They contribute many functionalities, such as immunity, heat tolerance, pregnancy, and cancer
(Hanif et al., 2018; Ioannidis & Donadeu, 2016). MiRNAs help suppress genes and play roles in
disease susceptibility and resistance (Wang et al., 2013).
2.7: MiRNA Databases and Reference Sequences
MiRNAs are still being discovered and understood with the help of several databases for
miRNAs, including miRBase, EVmiRNA, Dietary miRNA Database (DMD), miRGen, and
miRNEST. Jin et al. (2009) created a library of miRNAs found from select bovine tissues,
including liver, and compared their results to known species-specific miRNAs. Andreote et al.
(2014) created a library of miRNAs they found in domesticated chicken (Gallus gallus) skeletal
muscle. Chen et al. (2017) created a library for miRNAs found in Laiwu and Yorkshire pigs (Sus
scrofa). MiRNAs in zebu cattle (Bos indicus) and from databases showed that 736 of the 808
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domestic cattle (B. taurus) miRNAs were conserved in the zebu (Hanif et al., 2018). A Dorset
sheep (Ovis aries) miRNA library was created by researchers, with information about miRNA
conservation between B. taurus and O. aries species (Laganà et al., 2015). There is also a
database for food-borne miRNAs (Chiang et al., 2015).
2.8: MiR-122
MiR-122 is highly expressed in the liver of vertebrates (Chang et al., 2004; Jopling,
2012). Researchers have found that approximately 50 –72% of miRNAs per liver cell in mice
(Mus musculus) and humans are miR-122 (Jopling, 2012; Lagos-Quintana et al., 2002; Liang et
al., 2007). Heneghan et al. (2011) confirmed that miR-122 is expressed in blood, although it not
as highly expressed as in the liver. The alpha-helix coiled-coil rod homologue (HCR) gene and a
noncoding gene on chromosome 18 encode for miR-122 through the circadian process in various
mammals (Chang et al., 2004; Jopling, 2012). Researchers found that 3’ adenylation causes
greater miR-122 isoform stability (Jopling, 2012), and the half-life of miR-122 is estimated to be
over 24 h (Gatfield et al., 2009).
Factors that influence miRNA expression include disease, species, age, time of year, and
tissue type. Casas et al. (2016) reported that miR-122 in domestic cattle is upregulated in the
spring but downregulated in the summer. Liver of older animals, fetal muscle tissue, and oocytes
upregulate bta-miR-122 (Casas et al., 2016; Z. Wang et al., 2013). Serum miR-122 levels
increase post-mortem, especially when liver damage is present (Clarke et al., 2017). MiR-122
expression levels can be different between closely related species, such as yak (Bos grunniens)
and domestic cattle (Guan et al., 2017). MiR-122 levels in cynomolgus monkey (Macaca
fascicularis) plasma are high enough that detection doesn’t require pre-amplification (Iguchi et
al., 2018).
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Gustafson et al. (2016) suggested that sample contamination is likely if miR-122 is
detected when human liver is not present. However, since miR-122 is a circulating miRNA
present in serum, there can be positive results depending on slaughter conditions, presence of
blood, and physical condition of the sample before slaughter (Heneghan et al., 2011). High
circulating levels of miR-122 is associated with the presence of tumors and hepatic injury (Wang
et al., 2016). Research supports that miR-122 is highly expressed in the liver of most species,
including cattle (Gu et al., 2007; Sun et al., 2014). Studies have been conflicting on whether
miR-122 is found in adipose tissue, although most studies only analyze the miRNAs in a few
select tissues. Lagos-Quintana et al. (2002) found that miR-122 was liver-specific when
analyzing the following mouse tissues: heart, liver, kidney, lung, colon, midbrain, cortex,
cerebellum, small intestine, and spleen. Liang et al. (2007) tested over 40 healthy human tissues,
including adipose and liver. While the liver contained high expression of miR-122, they also
found 34 and 19 copies of miR-122 in brain and thymus tissues, respectively. Researchers such
as Liao et al. (2018) did not detect any miR-122 expression in the brain, however. Multiple
studies did not detect miR-122 in adipose tissue (Gu et al., 2007; Liang et al., 2007). Zhao et al.
(2009) stated that adipose tissue expresses miR-122 at levels 200 times less than the liver. Some
studies even suggest that miR-122 expression is differentiated between different types of adipose
tissue. Heneghan et al. (2011) discovered that miR-122 is expressed more in obese omental and
non-obese subcutaneous human adipose tissue. Liao et al. (2018) studied longissimus dorsi
intramuscular adipose tissue in Xinjiang brown cattle breeds. They found that miR-122 affected
adipocyte differentiation in both humans and cattle (Liao et al., 2018). Liao et al. (2018) also
showed that miR-122 expression distinguishes between subcutaneous and visceral human
adipose tissues. In contrast, many studies involving miRNA expression in adipose tissue-related
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research do not mention miR-122, possibly because it was not tested for or not detected (Romao
et al., 2012, 2014).
2.9: Rationale and Significance
Despite FDA enforcement of dietary supplement regulations, adulteration is still
occurring. Adulteration can infringe on religious practices and be harmful to human health due to
possible exposure to heavy metals, prions, and other contaminants. There is currently no
accepted method for detecting the authenticity of specific animal tissues declared to be in dietary
supplements. While miRNAs have a high potential for this application, they have not been tested
with dietary supplements. DNA-based methods, such as real-time PCR and DNA barcoding, are
successful for species identification in food products and could be used in a complementary
manner with miRNAs to authenticate both species and tissues in dietary supplements. However,
the combined use of these methodologies for this purpose has not been reported.
The objective of this study was to determine whether dietary supplements marketed as
containing “bovine liver” or “beef liver” were accurately labeled with regards to species and
tissue. The research utilized miRNA detection to verify the presence of vertebrate liver tissue
and a combination of DNA mini-barcoding and real-time PCR to identify species. The multiplex,
real-time PCR assay targeted the following species: cattle (Bos taurus), pork (Sus scrofa), horse
(Equus caballus), and sheep (Ovis aries) (Köppel et al., 2011). The hypothesis was that by using
highly expressed miRNAs, real-time PCR, and DNA mini-barcoding, sample species and tissues
would be verified in bovine/beef liver dietary supplements (Brown, 2017; Hellberg et al., 2019;
Newmaster et al., 2013; Sauer et al., 2017).
The following aims addressed the overall goal of determining the authenticity of species and
tissue type in dietary supplements containing animal tissues.
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Aim 1 tested for the presence of miR-122. MiR-122 has been isolated from liver,
adipose, and serum and was the marker used for target tissue detection (Jin et al.,
2009). Since miRNAs are relatively stable, they were expected to remain intact in
dietary supplements and be readily detected (Jin et al., 2009; Sauer et al., 2017).
Liver would only be identified if a positive result if the miRNA was found.



Aim 2 used multiplex real-time PCR to identify horse, cattle, sheep, and pork in
samples. This assay detected trace amounts of contaminant species present in a
mixture and identified multiple species simultaneously. The expectation was the
replacement of beef with a less expensive species, such as chicken (Hellberg et
al., 2017; USDA, 2020a).



Aim 3 used DNA mini-barcoding for species detection in samples that test
negative for all species targeted with real-time PCR (i.e., horse, cattle, sheep, and
pork). COI gene markers and online reference databases, BOLD and GenBank,
identified the species (Kane & Hellberg, 2016).

This was the first study to detect both miRNAs and DNA in dietary supplements containing
animal tissues. The results of this study provided a baseline for the current adulteration of dietary
supplements containing liver tissue in the United States market. The research will benefit
government agencies, consumers, and the research community by authenticating the animal
tissues declared in dietary supplements.
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3. Materials and Methods
Figure 2 is an experimental overview of the methodology used in this study. Subsequent
sections describe further details.

Figure 2: Overall procedure flow chart for dietary supplement analysis. White boxes indicate
procedures, white circles: analysis method, and bullnose boxes: sample type.
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3.1: Sample Collection and Preparation
Dietary supplements claiming to contain “bovine liver” or “beef” liver (n = 53) were
purchased from five online sources available to USA-based consumers. The 53 supplements
purchased were in the form of hard gelatin or vegetarian capsules (n = 40), tablets (n = 7), soft
gelatin capsules (n = 1), and powders (n = 5). Four of the supplements in powder form were
marketed specifically for pets, while the remaining supplements appeared to be intended for
human consumption. Each sample was assigned a sequential number and all information on the
label was recorded. Dietary supplement samples were prepared for molecular testing following
procedures described in Hellberg et al. (2019). Three solid-dosage units were removed from each
bottle, or three servings for powders, with sterile forceps for a single composite sample. Capsule
casings were removed and tablets were crushed using a mortar and pestle. The composite
samples were stored in sterile 50-mL CorningTM polypropylene conical centrifuge falcon tubes
(Corning, NY) at room temperature.
Positive and negative control samples were obtained for use with miRNA and DNA
testing. Horse DNA was purchased from Zyagen (San Diego, CA) and raw beef liver, beef
muscle, pork muscle, and lamb muscle cuts were purchased from local grocery stores in Orange
County, California. The beef liver was used as a positive control sample for miR-122 in miRNA
testing and the beef muscle was used as a negative control for miR-122. The horse DNA and raw
muscle cuts were used as species positive controls for DNA testing. Control sample muscle cuts
were verified for the correct species using multiplex real-time PCR, as described below. The raw
liver and muscle cuts were stored in re-sealable zipper storage bags at -80 °C following
collection and the horse DNA was stored at -20 °C. Prior to DNA extraction, the raw muscle cuts
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were thawed at 4 °C overnight. Samples of raw beef liver and raw beef muscle were kept at -80
°C without thawing before use for miRNA procedures (Sauer et al., 2017).
3.2: DNA Testing for Species Identification
All samples underwent DNA extraction and quantification, followed by real-time PCR.
In instances where real-time PCR failed to detect a species, DNA mini-barcoding was used.
3.2.1: DNA Extraction and Quantification
DNA was extracted according to the Qiagen (Hilden, Germany) DNeasy Blood & Tissue
Kit spin-column protocol for total DNA purification from animal tissues. Extraction was carried
out on 10 ± 5 mg of each composite dietary supplement sample and 25 ± 5 mg of control liver
and muscle samples. The sample weight was reduced for the dietary supplements because the
samples were dehydrated. Next, buffer ATL (180 μL) and proteinase K (20 μL) were added to
the tube. The sample was pulse-vortexed for 15 s and incubated in an Eppendorf Thermomixer C
(Hamburg, Germany) at 56 °C for 4 h. The mixture was vortexed for a total of 15 s, followed by
the addition of 200 μL buffer AL and another vortexing step. Next, 200 μL ethanol was added
and the mixture was vortexed to ensure adequate mixing. The solution was transferred to a 2 mL
collection tube and centrifuged at 6000 x g for 60 s. The flow-through and collection tube were
discarded. The sample was combined with 500 μL of buffer AW1 and placed in a new collection
tube, then centrifuged at 6000 x g for 1 min. Next, 500 μL AW2 was added and centrifuged at
20,000 x g for 3 min. The column was transferred to a new 1.5 mL micro-centrifuge tube and
200 μL buffer AE was pipetted onto the DNeasy membrane. After 1 min, the sample was
centrifuged at 6000 x g for 1 min. DNA was quantified using a Biophotometer Plus (Eppendorf).
The DNA extracts were diluted in AE buffer as needed to obtain a concentration of 20 ng/μL
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before use in real-time PCR. For each set of DNA extractions, a reagent blank control with no
sample added was also prepared.
3.2.2: Multiplex Real-Time PCR
Multiplex real-time PCR procedures were completed using the Tetraplex Real-Time PCR
AllHorseTM Assay (Microsynth AG, Balgach, Switzerland). Each reaction contained 7.5 μL of
the AllHorse Assay, 12.5 μL of QuantiTect Multiplex PCR NoROX (Qiagen, Hilden, Germany),
and 5 μL of DNA (20 ng/μL). The sample was placed in a Qiagen Rotor Gene Q thermocycler
and fluorescence detection was measured for ROX, JOE, Cy5, and FAM. The thermal cycling
protocol was as follows: 95 °C for 15 min, then 35 cycles of 95 °C for 10 s and 60 °C for 60 s.
Positive control samples for cattle, horse, pork, and sheep were included in each run. For every
PCR run, a non-template negative control with no DNA was included.
3.2.3: DNA Mini-Barcoding
Samples that failed species identification with real-time PCR underwent DNA barcoding
using the mini-barcode primers described in Wu et al. (2019) for mammals, poultry, and fish
(FishCOILBC_ts and REVshort1). Each reaction tube consisted of 12.50 μL 10% trehalose, 8.0
μL molecular grade water, 0.5 Omnimix bead (TaKaRa Bio, Inc, Otsu, Shiga, Japan), 0.25 μL
forward primer (10 μM), 0.25 μL reverse primer (10 μM), and 2.0 μL DNA template (20 ng/μL)
(Moore et al., 2012). Thermal cycling was carried out as follows: 94 °C for 5 min; 40 cycles of
94 °C for 30 s, 51 °C for 40 s, and 72 °C at 30 s; 72 °C for 10 min; then an indefinite hold at 4
°C (Wu et al., 2019). PCR products were stored at -20 °C. For every mini-barcoding sample set,
a non-template negative control with no DNA was included.
PCR products were confirmed as described in Kane and Hellberg (2015) using a pre-cast
2% agarose double comb E-gel (Life Technologies, Carlsbad, CA). Each sample well contained
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16 μL sterile water and 4 μL of PCR product. The gel was run for 15 min using an E-gel iBase
Power System (Life Technologies). Images of each gel were obtained by using a Fotodyne
Foto/Analyst 220-V UV transilluminator from Carolina Biological (Burlington, NC) and
PCIMAGE software. Samples with a positive PCR result and no indication of contamination
based on the negative controls underwent DNA sequencing.
PCR products were purified before DNA sequencing with ExoSAP-IT (Affymetrix, Santa
Clara, CA), according to the manufacturer’s instructions. Samples were shipped on ice overnight
to GenScript (Piscataway, NJ) for bi-directional sequencing with the M13 primers described in
Wu et al. (2019). Sequencing was carried out with a BigDye Terminator v3.1 Cycle Sequencing
Kit (Life Technologies) and 3730xl Genetic Analyzer (Life Technologies). The raw sequence
data were assembled and edited using Geneious R7 (Biomatters, Ltd., Auckland, New Zealand).
The resulting DNA sequences were searched against all public records in the Barcode of Life
Database (BOLD) to identify the top species matches. If a species match was not obtained with
BOLD, the sequence was searched in GenBank using the Basic Local Alignment Search Tool
(BLAST).
3.3: MiRNA Testing for MiR-122 Detection
3.3.1: MiRNA Extraction and Quantification
MiRNAs were extracted as total RNA using the mirVanaTM miRNA isolation kit (Life
Technologies), according to the manufacturer’s instructions. Samples were weighed into 1.5 mL
microcentrifuge tubes and then stored in a Nunc® Labtop Cooler (Nalge Nunc International,
Rochester, NY). The sample weights were the same as those used for DNA extraction. Next, the
lysis solution at 10x the sample weight (100-250 μL) was added to each sample tube and the
tubes were vortexed. MiRNA homogenate additive equal to the amount of sample (10-25 μL)
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was added and the tubes were vortexed and chilled in the Lab Top Cooler for 10 min. AcidPhenol:Chloroform equal to the amount of lysate (100-250 μL) was added and the tubes were
vortexed for 30-60 s before centrifuging at 10,000 x g for 5 min. The upper, aqueous phase
containing the RNA was transferred to a new 1.5 mL tube and the volume was recorded. The
steps for the enrichment of small RNAs in the mirVanaTM manual were followed to purify the
miRNAs from total RNA in the sample. Ethanol was added at 1/3 volume of the aqueous phase
and vortexed. The sample was pipetted onto a filter inside a collection tube and centrifuged for
30 s at 11,000 rpm (equivalent to 10,000 x g). Ethanol at 2/3 aqueous phase volume was added to
the filtrate, mixed gently, and pipetted onto another filter cartridge, and then the centrifuge
conditions were repeated. Next, the filter was washed with the mirVana wash solutions, followed
by centrifuging for 10 s after each wash and centrifuged for one min after the final wash. The
filter cartridge was placed in a new collection tube and 100 μL of pre-heated elution buffer (95
°C) was pipetted onto the filter before centrifuging for 30 s at 11,000 rpm.
Each extraction run included a reagent blank that contained no tissue sample to verify
that samples weren’t contaminated during preparation. Two extractions were performed on a cut
of beef muscle to serve as a negative control. The miRNA extracts were quantified with a
Biophotometer Plus (Eppendorf) and stored at -20 °C.
3.3.2: MiRNA Reverse-Transcription
The miRNA samples were thawed in a Labtop Cooler until completely melted.
Meanwhile, the work area and equipment were cleaned with RNaseZap. The reverse
transcription master mix was prepared according to the mixture used in the reverse transcription
step of the microRNA TaqMan analysis (Kotlarek et al., 2018). Each reagent mix included the
following per reaction: 100 mM dNTPs (0.15 μL), MultiScribe Reverse Transcriptase (1.00 μL),
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10x Reverse Transcription Buffer (1.50 μL), 20 U/μL RNase Inhibitor (0.19 μL), and nucleasefree water (4.16 μL). 5xRT primer (3 μL) and diluted sample miRNA (5 μL at 2ng/μL) was
added to a 0.2 mL reaction tube and placed in a thermocycler under the following conditions: 85
°C for 5 min and 60 °C for 5 min. After cycling, the sample was kept in the Labtop Cooler.
Reagent mix (7 μL) was added to each sample, mixed, and incubated in the Labtop Cooler for 5
min. Thermocycling conditions used the following parameters: 30 min at 16 °C, 30 min at 40 °C,
5 min at 85 °C, followed by holding at 4 °C. Samples were stored at -20 °C until further testing.
3.3.3: MiRNA Real-Time PCR
Real-time PCR amplification followed the TaqManTM Universal Master Mix II protocol
(Applied Biosystems, Foster City, CA). Each reaction tube contained 10.0 μL TaqManTM
universal master mix, no UNG, 7.67 μL nuclease-free water, 1.00 μL TaqManTM MicroRNA
Assay primer miR-122-5p (20X), and 1.33 μL reverse transcription product. The thermocycler
was set to FAM fluorescence detection and run under the following conditions: 95 °C for 10 min,
then 40 cycles of 95 °C for 15 s and 60 °C for 60 s. Reverse transcription and real-time PCR
were repeated on the same miRNA extract if a sample tested negative for miR-122 expression.
4. Results and Discussion
4.1: Sample Collection
The 53 beef/bovine liver dietary supplement products collected for this study represented
50 different brand names and 48 manufacturers. The average price per bottle was USD $19.83,
with a range of $4.65 to $36.00. The average price per dosage unit was $0.18 ± 0.10, with a
range between $0.02 and $0.67. Two samples did not declare the total amount of servings or
units/bottle. The majority of supplements declared a country of origin for the beef/bovine liver in
the product: 26 claimed Argentina, 11 claimed New Zealand, 2 claimed both New Zealand and
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Australia, 1 claimed the United States, 1 claimed the United States and Argentina, and 12 were
of undeclared geographical origin (Table 2). Two samples (Nos. 50 and 41) claimed to be
“handmade” or “homemade.” The majority of samples also claimed specific liver processing
methods on their labels or websites, such as desiccated (n=21), freeze-dried/lyophilized (n=10),
raw (n=4), predigested (n=2), cold processed (n=1), and undefatted (n=1) (Table 2). The
addresses included on the label for the manufacturer, distributor, or brand were primarily
associated with the United States (n=49), followed by New Zealand (n=1). Three of the products
did not have an address or manufacturing country listed.
In addition to bovine/beef liver, some of the most common ingredients declared in the
supplements included gelatin (n=33), silicon dioxide (n=20), magnesium stearate (n=20),
cellulose (n=19), rice (n=10), ginseng (n=5), and milk thistle (n=5). Six of the supplements (Nos.
5, 6, 21, 24, 31, and 45) claimed to contain additional tissues other than bovine/beef liver, with
the most common tissues being heart (n=3), kidney (n=3), bone (n=2), and spleen (n=2).
Specifically, sample No. 21 claimed to contain neonatal bovine spleen, heart, pancreas, kidney,
liver, adrenal complex, thymus, and lung, as well as lamb brain, pituitary/hypothalamus
complex, and intestine; sample No. 24 claimed to contain beef bone broth concentrate, liver,
heart and kidney; sample No. 31 claimed raw bovine testicular tissue, prostate tissue, heart
tissue, kidney tissue, and liver tissue; and sample No. 45 claimed bovine bone marrow, spleen,
and liver.
4.2: Species Identification with DNA
A total of 48/53 samples were confirmed to contain bovine species based on the
combined results of real-time PCR and DNA mini-barcoding (Table 2). Positive control samples
for pork, sheep, domestic cattle, and horse were all correctly detected with the multiplex real29

time PCR assay, with average Ct values of 29.14, 30.91, 27.24, and 25.62, respectively. The
multiplex real-time PCR assay detected domestic cattle in 35 samples. One of these samples (No.
21) tested positive for sheep/lamb in addition to cattle, both of which were declared on the label.
An additional sample (No. 11) tested positive for undeclared pork (Sus scrofa) in addition to
cattle. The only ingredients listed for this sample were “desiccated beef liver powder” and
“vegetable capsule,” indicating potential mislabeling.
Among the 18 samples that failed real-time PCR, 13 were identified using DNA minibarcoding (Table 2). DNA mini-barcoding identified eight of the samples specifically as B.
taurus, and five to the Bos genus, with equivalent top matches to B. taurus, Bos frontalis (gayal),
and B. taurus indicus (zebu). The genetic marker used for DNA barcoding and mini-barcoding of
animal species (COI) is part of the mitochondrial DNA, which is inherited maternally and cannot
distinguish between hybrid and purebred species (Kane & Hellberg, 2016). Hybridization may
explain why some of the samples showed equivalent matches to multiple Bos species. Gayal,
also called mithun, is the semi-domesticated species of the endangered guar. Gayal is considered
endangered in Bangladesh, and there is evidence that gayal has reproduced with B. taurus
(Faruque et al., 2015). Therefore, it is likely that some of the BOLD records for gayal contain
identical DNA sequences to those for domestic cattle, resulting in an equivalent genetic match to
these species. Zebu is a subspecies of B. taurus that acclimated to tropical climates before
becoming domesticated (Porto-Neto et al., 2013). In addition to the possibility of historical
hybridization events, it may be that the mini-barcode targets a section of the mitochondrial
genome that has little or no sequence divergence between these closely related species.
Among the five unidentified samples, two failed to produce a sequence and three had
short sequence lengths (<71 bp) that did not have a species match in BOLD or GenBank.
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However, there were no trends explaining why these samples failed. While all these samples
claimed to contain Argentinean beef/bovine liver, other samples that declared Argentinean
beef/bovine liver were successfully identified. The most commonly declared ingredients in these
products were rice (n=3), ginseng (n=3), milk thistle (n=3), gelatin (n=3), silicon dioxide (n=3),
magnesium stearate (n=2) and cellulose (n=1). Ingredients such as gelatin may interfere with
DNA extraction and amplification, leading to a higher percentage of failed sequences (Wallace et
al., 2012). However, these ingredients were also declared in products that were identified using
real-time multiplex PCR or DNA mini-barcoding. Two of the failed samples claimed to contain
desiccated liver, while the other three listed no processing methods. In comparison, there were
19 successfully identified samples that claimed to contain desiccated liver. It is important to note
that while the lack of species detection suggests potential mislabeling, it does not confirm
mislabeling. It might instead indicate a high level of DNA degradation or a need for further
optimization of the testing method for use with dietary supplements (Zahn et al., 2020).
Additionally, the presence of DNA from plant or other animal species could have interfered with
DNA sequencing.
Interestingly, the majority (92.3%) of samples identified with DNA mini-barcoding failed
to produce a sequence read with the forward primer but were identified based on the single
sequence read associated with the reverse primer. Wu et al. (2019) reported that these minibarcode primers were successful at identifying B. taurus in samples processed under high
temperature/high pressure conditions, but not whether bidirectional sequences were obtained. A
study on DNA barcoding of meat and poultry products using the universal mini-barcode primers
developed by Meusnier et al. (2008) found low success rates for mini-barcoding compared to
full-barcoding, which they attributed to less success with primer binding (Hellberg et al. 2017).
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The primer sequences used in the current study were different from those developed by Meusnier
et al. (2008), but the forward primer targeted a similar region of the COI gene. While bidirectional sequencing is not always necessary to accurately identify species in a sample,
optimization of the forward mini-barcode primer used in the current study might help to improve
the identification of species in these products.
Real-time PCR and DNA barcoding have been used in multiple studies to detect food and
dietary supplement fraud (Hellberg et al., 2019; Kane & Hellberg, 2016; Newmaster et al.,
2013). The 2% species mislabeling rate reported in the current study is lower compared to other
market surveys on dietary supplement mislabeling, which have reported mislabeling rates of 19 –
45% (Hellberg et al., 2019; Morovic et al., 2016; Newmaster et al., 2013; Wallace et al. 2012).
The low species mislabeling rate in the current study could be due to high availability of bovine
liver for use in supplements and low incentive for substitution. However, it is important to
mention that the multiplex real-time PCR used in the current study only tests for pork, horse,
sheep, and domestic cattle, and not the presence of any other species (Köppel et al., 2011). If a
supplement contained additional species, they would not have been detected with this assay.
4.3: Organ Verification with MiRNA Detection
MiRNA real-time PCR detected miR-122 in 51 of the 53 supplements (Table 2). Fifteen
samples had Ct values ≤ 26 and the remaining 38 samples had Ct values between 30 and 39.
Interestingly, all samples claiming to contain Argentinean beef had Ct values ≥ 30. Beef could
have been processed in Argentina before being shipped to the manufacturer, causing sample
degradation and higher Ct values. Two supplements (sample Nos. 7 and 33) repeatedly tested
negative for miR-122. Sample 7 was positive for beef with the multiplex real-time PCR species
assay and sample 33 failed multiplex real-time PCR but was positive for Bos spp. with DNA
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mini-barcoding. These results indicate that the samples contained bovine species but possibly not
liver from these species. Both samples that failed miR-122 detection claimed to contain
Argentinean beef liver and contained cellulose and magnesium stearate. However, other samples
with these ingredients were able to be detected with this assay. Sample 33 claimed to contain
predigested liver fractions, which may be more hydrolyzed and could explain why miR-122 was
not detected. While previous research has shown that miR-122 is stable and detectable despite
degradation, there are some discrepancies (Bail et al., 2010; Courts & Madea, 2010; Jin et al.,
2009; Mraz et al., 2009). For example, miR-122 levels fluctuate depending on disease presence
and growth development stage (Casas et al., 2016; Wang et al., 2013; Clarke et al., 2017; Guan
et al., 2017; Iguchi et al., 2018).
Interestingly, all five samples that could not be identified with DNA testing contained
miR-122. These results suggest that liver was likely present in the supplements, but the species
could not be confirmed. The non-template controls and reagent blanks for all trials were
negative. However, one of the two negative control beef muscle extracts was positive for miR122 with a Ct value of 38.24. The PCR assay was repeated for both beef muscle extracts and they
were both negative for miR-122, indicating a possible contamination event or weakly positive
signal in the first run.
It is important to note that miR-122 is a circulating miRNA and detection of this miRNA
does not guarantee that liver is undeniably present. Previous researchers have found low copies
of miR-122 in other tissues, such as spleen and adipose tissue, while other studies found no
copies of miR-122 in these tissues (Lagos-Quintana et al. 2002; Liang et al. 2007; Liao et al.
2018; Gu et al. 2007; Zhao et al. 2009; Heneghan et al. 2011; Li et al. 2018). MiRNA panels may
be more reliable at verifying liver presence since miR-122 is not exclusively expressed in the
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liver. For example, muscle-specific miRNAs for beef are miR-1, miR-133a, and miR-206 (Jin et
al., 2009). MiR-9 and miR-124, although found in small amounts in other bovine tissues, can be
used to identify brain tissue (Jin et al., 2009). Other miRNAs reported as highly expressed
include miR-451 (spleen) and miR-30a (kidney) (Jin et al., 2009). Species-specific miRNAs are
being discovered. Examples include miRNAs miR-411, -423-5p, -574-3p, and -652 in beef (Jin
et al., 2009). Since miRNAs are often conserved among species in addition to being tissuespecific, it is possible that miRNAs can be used as universal tissue biomarkers (Jin et al., 2009).
More research should be conducted to find suitable miRNAs conserved across species for use as
universal tissue biomarkers.
MiRNAs also have potential use as indicators to determine if companies are using
healthy animals within the expected age. Since miRNA expression differs among sick and
healthy animals, detection of miRNA levels in animals can help determine the health status of
the animal before slaughter (Forero-Forero, Gonzalez-Teshima, Capal-Herrera, Ramirez-Cheyne,
& Castillo-Giraldo, 2016). If veal (bovine < 18 weeks old) is claimed on the label, miRNAs can
also be used to determine the age of the animal (Forero-Forero et al., 2016; USDA, 2011).
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Table 2: Results of miRNA and DNA identifications for bovine liver supplements tested in this study. Samples were only subjected to
DNA mini-barcoding if the real-time PCR assay failed to identify a species
Sample Form
No.

Labeled
species

1
2
3

Capsule
Capsule
Capsule

Beef
Beef
Beef

4
5

Softgel
Capsule

6

Tablet

7
8

Tablet
Capsule

9

Tablet

10
11

Beef/bovine Processing claim(s)
origin

Argentina
Argentina
New
Zealand
Bovine
Undeclared
Beef
United
States
Beef/Bovine Argentina

Desiccated
Desiccated
Cold Processed

MicroRN
A-122 Ct
value
32.75
35.48
19.27

Predigested
Freeze Dried

36.74
20.58

Beef (32.66)
Beef (21.39)

N/A
N/A

Raw

31.12

ND

Desiccated
Undeclared

NDb
19.21

Beef (28.13)
Beef (20.79)

Undeclared

30.2

Beef (23.95)

N/A

Tablet
Capsule

Beef/Bovine Argentina
Bovine
Australia
and New
Zealand
Bovine
BSE-Free
Countries
Beef
Argentina
Beef
Argentina

B. taurus/B.
frontalis/B.
taurus indicus
(100%)
N/A
N/A

Desiccated
Undeclared

36.34
31.42

N/A
N/A

12
13

Capsule
Tablet

Beef
Beef

Argentina
Argentina

Desiccated
Desiccated

31.65
34.27

Beef (32.66)
Pork (37.11),
Beef (28.35)
Beef (38.14)
ND

14

Capsule

Beef/Bovine Argentina

Undeclared

35.27

ND

15

Capsule

Beef

Desiccated

32.64

Beef (34.69)

Argentina
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Real-Time
PCR Species
ID (Ct)
Beef (29.53)
Beef (27.19)
Beef (21.63)

DNA minibarcoding ID
(% similarity)a
N/A
N/A
N/A

N/A
B. taurusc
(95.65%)
B. taurus/B.
frontalis/B.
taurus indicus
(100%)
N/A

16
17

Capsule
Capsule

Desiccated
Freeze Dried

34.21
20.41

Beef (37.83)
Beef (27.03)

N/A
N/A

Capsule

Beef
Argentina
Beef/Bovine New
Zealand
Beef
Argentina

18

Desiccated

38.44

ND

19

Capsule

Bovine

Undeclared

20.14

Beef (27.08)

No species
match
N/A

20

Capsule

Beef

32.81

Beef (30.93)

N/A

21

Tablet

Bovine,
Ovine

Desiccated/Freeze
Dried
Undeclared

33.07

N/A

22

Capsule

Beef

Raw

22.18

23

Capsule

Freeze Dried

26.03

Beef (24.17)

N/A

24

Capsule

New
Zealand
Bovine
New
Zealand
Beef/Bovine Argentina

Beef (26.27),
Sheep
(33.00)
Beef (29.18)

35.81

Beef (31.57)

N/A

25

Capsule

Beef

Undefatted,
Desiccated, Freeze
Dried
Undeclared

34.34

ND

26

Capsule

Beef

Desiccated

32.66

Beef (31.96)

27

Capsule

New
Zealand
Beef/Bovine Undeclared

No species
match
N/A

Freeze Dried

31.1

ND

28

Capsule

Bovine

Undeclared

21.55

Beef (25.90)

29
30
31

Capsule
Capsule
Capsule

Beef
Beef
Bovine

36.7
37.56
33.5

Beef (23.67)
Beef (36.62)
Beef (32.50)

N/A
N/A
N/A

32

Tablet

Bovine

Argentina
Argentina
US and
Argentina
Undeclared

Desiccated/Freeze
Dried
Undeclared
Desiccated
Raw

B. taurus
(99.25%)
N/A

Undeclared

21.25

Beef (28.71)

N/A

Australia
and New
Zealand
New
Zealand
Undeclared

Argentina

36

N/A

33

Capsule

Beef

Argentina

Predigested

ND

ND
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Capsule

Beef/Bovine Argentina

Desiccated

35.09

ND

35

Capsule

Bovine

Desiccated

20.81

Beef (26.50)

36

Capsule

Bovine

Freeze Dried

24.58

Beef (27.32)

N/A

37

Capsule

Beef

New
Zealand
New
Zealand
Argentina

Bos spp.
(100%)
No species
match
N/A

Undeclared

35.82

ND

38

Capsule

Beef

Argentina

Undeclared

36.09

ND

39

Capsule

Beef

Undeclared

26.04

Beef (28.70)

40

Capsule

Beef

New
Zealand
Argentina

B. taurus
(100%)
Failed
sequencing
N/A

Undeclared

32.14

ND

41

Capsule

Beef

Undeclared

Handmade

37.34

ND

42
43
44

Powder
Capsule
Capsule

Beef
Argentina
Beef/Bovine Argentina
Bovine
Undeclared

Desiccated
Desiccated
Raw/Lyophilized

35.71
32.13
36.98

Beef (30.53)
Beef (30.00)
ND

45

Capsule

Bovine

Undeclared

Undeclared

22.72

46

Capsule

Beef

Undeclared

Undeclared

31.71

Bovine
(27.35)
ND

47

Capsule

Bovine

Beef (26.80)

Powder

Beef

Desiccated/Freeze
Dried
Desiccated

19.72

48

New
Zealand
Undeclared

B. taurus/B.
frontalis/B.
taurus indicus
(97.73%)
N/A

33.08

Beef (32.12)

N/A

37

B. taurusc
(94.51%)
B. taurus/B.
frontalis/B.
taurus indicus
(100%)
N/A
N/A
B. taurus
(100%)
N/A

49

Powder

Beef

Undeclared

Undeclared

34.99

ND

B. taurus
(100%)
50
Powder Beef
Argentina
Homemade
32.53
ND
B. taurus
(100%)
51
Capsule Beef
New
Undeclared
34.01
ND
B. taurus
Zealand
(100%)
52
Powder Beef
Argentina
Undeclared
33.14
ND
Failed
sequencing
53
Capsule Beef
Argentina
Desiccated
32.23
Beef (30.51) N/A
a
Results are shown as the top species match and % genetic similarity to reference sequences in BOLD/GenBank
b
ND = Not detected
c
GenBank was used because species could not be identified with BOLD
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5. Conclusions
This was the first study to use microRNAs for verification of animal tissues in dietary
supplements, as well as the first study to focus on the identification of specific animal tissues in
dietary supplements. The combined use of real-time multiplex PCR and DNA mini-barcoding
was successful at detecting genus or species for the majority (90.6%) of samples. Individually,
real-time multiplex PCR identified 66.0% of samples and DNA mini-barcoding identified an
additional 24.5% of the samples. Real-time multiplex PCR was beneficial for targeted screening
for the presence of beef and other domesticated species. At the same time, DNA mini-barcoding
was able to resolve some of the samples not identified using real-time PCR. The results of this
study indicate the benefits of using both methods when detecting species in a highly processed
sample. However, the inability to identify species in close to 10% of the samples tested indicates
the need for further optimization of these methods for use with dietary supplements. MiR-122
detection was successful for 96.2% of samples, indicating the presence of liver in most products.
However, since miR-122 is a circulating miRNA, it can be detected even when liver is absent.
Future research using a panel of miRNAs is recommended for additional confirmation of tissue
type. Further development and validation of this method will ultimately enable rapid
confirmation of both the species and tissue type declared in dietary supplements and other highly
processed products.
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